Q2 2024 CareDx Inc Earnings Call Transcript
Key Points
- CareDx Inc (CDNA) reported a 31% year-over-year increase in total revenue for the second quarter, reaching $92.3 million.
- The company achieved a significant milestone by becoming adjusted EBITDA positive this quarter, with a gain of $12.9 million compared to a loss in the same quarter last year.
- CareDx Inc (CDNA) raised its full-year 2024 revenue guidance to $320 million to $328 million, reflecting a growth rate of 15% year-over-year at the midpoint.
- The company's testing services business saw a 33% year-over-year revenue increase, with 43,700 tests delivered, marking the fourth consecutive quarter of sequential growth.
- CareDx Inc (CDNA) achieved over $10 million in revenue from both its patient and digital solutions and lab products businesses, with year-over-year growth rates of 19% and 35%, respectively.
- The company's non-GAAP gross margin for products decreased to 47% from 59% in the same quarter last year.
- Despite the positive adjusted EBITDA, the company remains cautious about future collections from prior periods, indicating a shrinking pool of such opportunities.
- The company faces uncertainties regarding the finalization of the draft Medicare local coverage determination, which could impact future revenue.
- CareDx Inc (CDNA) did not provide specific volume growth data at the organ level, which may limit detailed analysis of growth drivers.
- The company acknowledged that the overall pool of opportunities for improved collections from prior periods is decreasing, potentially impacting future revenue growth.
Good day, everyone, and welcome to today's Care Dx Incorporated second quarter 2024 earnings conference call. (Operator Instructions) Please note this call may be recorded and I'll be standing by if you should need any assistance.
And it is now my pleasure to turn the call over to Mr. Greg Chodaczek. Managing Director.
Thanks, Leo, and good afternoon and thank you for joining us today. Earlier today, Care Dx released financial results for the quarter ending June 30, 2024 the release is currently available on the company's website at www.Caredx.com. John Hanna, President and Chief Executive Officer and Abhishek Jain, Chief Financial Officer will host this afternoon's call.
Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the Safe Harbor provisions
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
